Ernesto Gomez, MD
Obstetrics & Gynecology · Mesa, AZNPI 1386685055
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $121,500 of the $145,282 with a category attached, or 83.6%. AbbVie accounts for 97.7% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2019 at $89,267 and has fallen 99.8% since, to $216 in 2025. Among obstetrics & gynecology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 393 payments — averaging $369.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$142K
- Coloplast$576
- Daiichi Sankyo Inc.$441
- Hologic Sales And Service, LLC$423
- Intuitive Surgical$289
- Millicent US Inc$199
- plus $1K from 20 others
Across 239 payments — averaging $5698.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$600K
- Exeltis, USA Inc.$297K
- Mylan Inc.$274K
- Sumitomo Pharma America, Inc.$119K
- Organon$45K
- Myovant Sciences Inc.$21K
- plus $5K from 2 others
What the payments were for
- Speaking & faculty fees$121,50084%
- Travel & lodging$16,92312%
- Food & beverage$6,7035%
- Education$1380%
- Gifts$180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 254 | $141,942 |
| Coloplast | 8 | $576 |
| Daiichi Sankyo Inc. | 56 | $441 |
| Hologic Sales And Service, LLC | 4 | $423 |
| Intuitive Surgical | 3 | $289 |
| Millicent US Inc | 11 | $199 |
| Sumitomo Pharma America, Inc. | 10 | $172 |
| Astellas Pharma US Inc | 3 | $164 |
| Therapeuticsmd, Inc. | 8 | $159 |
| Stryker | 1 | $148 |
| Organon | 1 | $138 |
| Myovant Sciences Inc. | 6 | $118 |
| Sage Therapeutics, LLC | 1 | $104 |
| Pfizer | 4 | $64 |
| Shield Therapeutics Inc | 3 | $56 |
| AMAG Pharmaceuticals, Inc. | 3 | $44 |
| Mayne Pharma Commercial LLC | 4 | $44 |
| Lupin Inc. | 3 | $42 |
| Alfasigma USA, Inc. | 2 | $29 |
| Biogen | 1 | $28 |
| Bayer | 2 | $28 |
| Ascend Therapeutics US, LLC | 1 | $18 |
| Boston Scientific | 1 | $17 |
| Exeltis, USA Inc. | 1 | $14 |
| Baxter Healthcare | 1 | $14 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$125,626
- ORIAHNN$27,251
- ALTIS$481
- NovaSure$258
- MYOSURE TISSUE REMOVAL DEVICE$258
- OMNI HYSTEROSCOPE$140
- JADA SYSTEM$138
- Acessa$125
- ACESSA PROVU SYSTEM$119
- MYRBETRIQ$115
- Da Vinci Surgical System$111
- BIJUVA$105
- ZULRESSO$104
How this compares
$145,282 in reported general payments places this provider in the 95th percentile of 757 obstetrics & gynecology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 51 | $38,734 |
| Estradiol | 234 | $12,200 |
| Estradiol (Twice Weekly)Estradiol | 73 | $8,046 |
| ProgesteroneProgesterone, Micronized | 104 | $4,211 |
| Liothyronine Sodium | 62 | $2,601 |
| Estradiol (Once Weekly)Estradiol | 23 | $1,179 |
| Raloxifene Hcl | 26 | $1,009 |
| Testosterone Cypionate | 63 | $581 |
| Spironolactone | 30 | $572 |
| Clobetasol Propionate | 16 | $532 |
| Oxybutynin Chloride ErOxybutynin Chloride | 14 | $479 |
| Levothyroxine Sodium | 50 | $394 |
| Hydroxyzine Hcl | 14 | $217 |
| Ketoconazole | 16 | $188 |
| Fluconazole | 18 | $174 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $164 | $38,73451 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 757 obstetrics & gynecology providers in Arizona.
Other obstetrics & gynecology in Mesa
- Sidney SemradMesa$17K
- Mily NievesMesa$12K
- Daniel RowlandMesa$10K
- Eericca BickleyMesa$8K
- Catherine BrainardTucson$302K
- Micah HarrisScottsdale$217K
- Steven NelsonPhoenix$159K
- Bj HoPhoenix$134K
- Chijioke SoribePhoenix$117K
- Shruti BalaTucson$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.